BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 116316
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.116316
Figure 1
Figure 1 Family pedigree of the proband. Black arrow: Our patient (the proband).
Figure 2
Figure 2 Relative abundance of fecal bacterial taxa in a pediatric patient with colon cancer and a matched healthy control. The charts depict the composition of the fecal microbiota at the phylum, genus, and species levels, showing the relative abundance of each taxon in both individuals. Basic metadata for the patient and healthy control are included for comparison. A: Healthy control; B: Patient.
Figure 3
Figure 3 Clinical timeline of a pediatric patient with colon cancer from symptoms onset to current status. Dates are shown in month/year format to clarify the chronological sequence of the patient’s clinical history. XELOX: Oral capecitabine and oxaliplatin; HIPEC: Hyperthermic intraperitoneal chemotherapy.


Write to the Help Desk